Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II.

Zhou MS, Adam AG, Jaimes EA, Raij L.

Hypertension. 2003 Nov;42(5):945-51. Epub 2003 Sep 15.

2.

Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.

Zhou MS, Schulman IH, Raij L.

Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H833-9. doi: 10.1152/ajpheart.01096.2008. Epub 2009 Jan 16.

3.

Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.

Zhou MS, Hernandez Schulman I, Pagano PJ, Jaimes EA, Raij L.

Hypertension. 2006 Jan;47(1):81-6. Epub 2005 Dec 12.

4.

Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.

Zhou MS, Jaimes EA, Raij L.

Hypertension. 2004 Aug;44(2):186-90. Epub 2004 Jul 6.

6.

Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.

Zhou MS, Tian R, Jaimes EA, Raij L.

Am J Hypertens. 2014 Jun;27(6):873-80. doi: 10.1093/ajh/hpt272. Epub 2014 Jan 11.

PMID:
24413709
7.
8.

Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species.

Jaimes EA, Zhou MS, Pearse DD, Puzis L, Raij L.

Am J Physiol Renal Physiol. 2008 Feb;294(2):F385-92. Epub 2007 Dec 19.

9.

Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity.

Harrison-Bernard LM, Schulman IH, Raij L.

Hypertension. 2003 Dec;42(6):1157-63. Epub 2003 Nov 10.

10.

Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.

Zhou MS, Schulman IH, Raij L.

J Hypertens. 2010 Mar;28(3):527-35. doi: 10.1097/HJH.0b013e3283340da8.

PMID:
19898250
11.

Thiazide diuretics, endothelial function, and vascular oxidative stress.

Zhou MS, Schulman IH, Jaimes EA, Raij L.

J Hypertens. 2008 Mar;26(3):494-500. doi: 10.1097/HJH.0b013e3282f3e39d.

PMID:
18300860
12.

Effects of angiotensin II AT₁-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats.

Kosaka S, Pelisch N, Rahman M, Nakano D, Hitomi H, Kobori H, Fukuoka N, Kobara H, Mori H, Masaki T, Cervenka L, Matsumura Y, Houchi H, Nishiyama A.

J Pharmacol Sci. 2013;121(2):95-102. Epub 2013 Jan 22.

13.

Bone marrow transplantation improves endothelial function in hypertensive Dahl salt-sensitive rats.

Yu H, Shao H, Yan J, Tsoukias NM, Zhou MS.

J Am Soc Hypertens. 2012 Sep-Oct;6(5):331-7. doi: 10.1016/j.jash.2012.08.003.

14.
15.

Effects of benidipine and candesartan on kidney and vascular function in hypertensive Dahl rats.

Yao K, Sato H, Sonoda R, Ina Y, Suzuki K, Ohno T.

Hypertens Res. 2003 Jul;26(7):569-76.

16.

Regression of glomerular and tubulointerstitial injuries by dietary salt reduction with combination therapy of angiotensin II receptor blocker and calcium channel blocker in Dahl salt-sensitive rats.

Rafiq K, Nishiyama A, Konishi Y, Morikawa T, Kitabayashi C, Kohno M, Masaki T, Mori H, Kobori H, Imanishi M.

PLoS One. 2014 Sep 18;9(9):e107853. doi: 10.1371/journal.pone.0107853. eCollection 2014.

17.

Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.

Kobayashi N, Ohno T, Yoshida K, Fukushima H, Mamada Y, Nomura M, Hirata H, Machida Y, Shinoda M, Suzuki N, Matsuoka H.

Am J Hypertens. 2008 May;21(5):576-81. doi: 10.1038/ajh.2008.27. Epub 2008 Mar 20.

PMID:
18437150
19.

[Up-regulation of intrarenal renin-angiotensin system contributes to renal damage in high-salt induced hypertension rats].

Wu HY, Liang YX, Bai Q, Zhuang Z, A LT, Zheng DX, Wang Y.

Beijing Da Xue Xue Bao. 2015 Feb 18;47(1):149-54. Chinese.

20.

Effects of renin-angiotensin system blockade and dietary salt intake on left ventricular hypertrophy in Dahl salt-sensitive rats.

Sugimoto K, Fujimura A, Takasaki I, Tokita Y, Iwamoto T, Takizawa T, Gotoh E, Shionoiri H, Ishii M.

Hypertens Res. 1998 Sep;21(3):163-8.

Supplemental Content

Support Center